As of Nov 27
| +0.11 / +0.58%|
The 6 analysts offering 12-month price forecasts for Depomed Inc have a median target of 28.50, with a high estimate of 35.00 and a low estimate of 24.00. The median estimate represents a +48.98% increase from the last price of 19.13.
The current consensus among 6 polled investment analysts is to Buy stock in Depomed Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.